Efficacy of Bloodletting Therapy in Patients with Chronic Idiopathic Urticaria: A Randomized Control Trial.
Biru MaXiuhua ChenYudan LiangWeiquan OuyangBoyan TangFanqi MengXiaohong QuanCong WangYing LiDacan ChenPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
In this study on patients with CIU, one month of bloodletting therapy combined with ebastine is clinically beneficial compared with placebo treatment combined with ebastine and treatment with ebastine only. Thus, bloodletting therapy can be an effective complementary treatment in CIU. This trial is registered with ChiCTR1800015294.